Latest round in the stent controversy favours sirolimus eluting stentsBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7620.587-a (Published 20 September 2007) Cite this as: BMJ 2007;335:587
In response to ongoing controversy about the safety of drug eluting stents compared with bare metal stents, researchers analysed data from 38 randomised trials including more than 18 000 people with coronary ischaemia. Bare metal stents, paclitaxel eluting stents, and sirolimus …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial